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Abstract:  
Purpose: A straightforward, noninvasive method is needed to assess emphysema and 
pulmonary hypertension (PH) in COPD patients. The desaturation–distance ratio (DDR) 
is an index derived from the distance traveled and level of desaturation during a six-
minute walk test (6MWT); it has previously been shown to be associated with percentage 
of forced expiratory volume in the first second of expiration (%FEV1.0) and percentage 
of diffusion capacity of the lung for carbon monoxide (%DLCO). The aim of this study 
was to examine the associations between DDR and emphysema and PH. 
Patients and methods: We collected the following data for 74 stable COPD outpatients: 
lung function tests (%FEV1.0 and %DLCO), 6MWT distance and desaturation, and area 
of emphysema on computed tomography (percentage of low attenuation area). 
Enlargement of the pulmonary artery (PA) was assessed by the ratio of the diameter of 
the PA to that of the aorta (PA:A ratio) as an index of PH. DDR was calculated by the 
distance traveled and the degree of desaturation reached during a 6MWT. The 
relationships between study outcomes were assessed with Spearman’s rank-correlation 
analysis. Receiver operating characteristic (ROC) curves were used to determine the 
threshold values with the optimum cutoff points for predicting severe or very severe 
airway obstruction, pulmonary diffusing capacity disorder, moderate or severe 
emphysema, and enlargement of the PA. 
Results: DDR correlated significantly with %FEV1.0, %DLCO, %LAA, and PA:A ratio. 
DDR showed high accuracy (area under the ROC curve >0.7) for predicting severe or 
very severe airway obstruction, pulmonary diffusing capacity disorder, moderate or 
severe emphysema, and enlargement of the PA. 
Conclusion: The results suggest that DDR is a good index of emphysema and PH in 
COPD patients. The 6MWT is widely used to assess COPD, and DDR could help with 
the early diagnosis of COPD. 
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Introduction 
COPD is characterized by airflow obstruction and emphysema.1,2 These two conditions 
commonly coexist, often with different degrees of severity;3 indeed, emphysema has been 
confirmed in smokers without airflow obstruction.4–7 Emphysema affects quality of life and has 
been shown to be associated with exacerbations of COPD and deteriorating pulmonary function.7 
Pulmonary hypertension (PH) is an important serious comorbidity of COPD, which has been 
shown to be associated with the exacerbation of COPD and mortality.8,9 Right heart 
catheterization (RHC) is the gold standard method for the diagnosis or evaluation of PH,10,11 but 
it can be difficult in practice to provide all COPD patients with RHC because of its high degree 
of invasiveness.9 The ratio of the diameter of the pulmonary artery (PA) to that of the aorta (PA:A 
ratio), measured by computed tomography (CT), is an index for enlargement of the PA, a 
condition independently related to exacerbations in COPD patients.12 The PA:A ratio has been 
reported to be superior to echocardiography in the diagnosis of resting PH in patients with severe 
COPD.13 Indeed, CT provides a range of information about COPD, including the extent of 
emphysema and PH, but it cannot be used in all situations. An easier noninvasive method that 
takes account of the various manifestations of COPD is needed for early diagnosis. 
The six-minute walk test (6MWT) is a straightforward and low-cost test used worldwide to 
evaluate the exercise capacity of patients with COPD.14 The six-minute walk distance (6MWD) 
and the degree of exercise-induced oxygen desaturation (EID) measured during the 6MWT have 
been shown to be related to emphysema and PH in COPD patients.15–18 The desaturation–
distance ratio (DDR), calculated from the 6MWD and the degree of EID during the 6MWT, has 
recently been proposed as an index for the assessment of interstitial lung disease.19 The DDR 
has been shown to be associated with pulmonary function in COPD patients, including the 
degree of airflow obstruction and pulmonary diffusing capacity.19,20 However, there have been 
no reports examining whether the DDR was related to the degree of emphysema or PH in 
COPD patients. The aim of this study, therefore, was to examine whether the DDR could be 
used to assess emphysema and PH in COPD patients. 
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Patients and methods 
Study subjects 
The outpatients with stable COPD who visited Kobe City Medical Center West Hospital between 
2014 and 2016 were enrolled in this study. The diagnosis of COPD was based on the following 
criteria: age >40 years, a smoking history of ≥20 pack-years, and a ratio of the forced expiratory 
volume in the first second of expiration (FEV1.0) to forced vital capacity (FVC) <70%. The 
subjects were classified according to the Global initiative for chronic Obstructive Lung Disease 
(GOLD) airflow limitation. In addition, clinical symptoms such as a chronic cough, sputum, or 
dyspnea and smoking history, and/or emphysema on CT were included in the physician’s 
diagnosis of COPD at risk (GOLD stage 0), even if FEV1.0/FVC was >70%.21–25 The following 
exclusion criteria were applied: a previous lung surgical procedure, exacerbation for at least 3 
months prior to undergoing the 6MWT, inability to accurately perform the 6MWT, lung function 
test, and CT, and the use of long-term oxygen therapy. Figure 1 presents a flow diagram of subject 
enrollment. The study protocol was approved by the ethics committee of Kobe University (N287, 
Kobe, Japan). All subjects provided written or verbal informed consent. 
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Six-minute walk test 
The 6MWT was administered according to the American Thoracic Society (ATS) guidelines.26 
It was performed indoors on a flat square course with 25-m long sides, supervised by a 
physician and a physical therapist. Each subject was asked to walk as far as possible around the 
course in six minutes, during which the modified Borg scale was recorded each minute as a 
measure of dyspnea. Every two seconds, peripheral oxygen saturation (SpO2) and pulse rate 
were recorded using WristOx (model 3150; Nonin Medical, Plymouth, MN, USA); these data 
were analyzed by WristOx2 software (Star Product, Tokyo, Japan). 
The DDR was calculated as the ratio of the desaturation area (DA) to the 6MWD. We used two 
versions of the DDR (DDR-original and DDR-simple) based on different ways of calculating 
DA as proposed in previous studies.19,20 For DDR-original, DA was obtained from the sum of 
the differences between 100% and the recorded SpO2 sampled every two seconds.19 For DDR-
simple, DA was obtained from the sum of the differences between 100% and the recorded SpO2 
sampled once a minute.20 
 
Lung function test 
The lung function test was performed according to the ATS guidelines27 and measured FVC, 
FEV1.0, and the diffusion capacity of the lung for carbon monoxide (DLCO). Each was 
expressed as percentages of the predicted values (%FVC, %FEV1.0, and %DLCO, respectively). 
 
Extent of emphysema and PA:A ratio 
CT was performed using Optima CT 660 Discovery (GE Healthcare, Little Chalfont, UK). 
Emphysema was identified by the percentage of low attenuation area (%LAA) across all lung 
fields.28–30 The Goddard Score was used as an index of the severity of emphysema.31 
Measurement of the PA:A ratio followed the method described in previous studies.12,13 The 
diameters of the PA and the aorta at the level of the bifurcation were measured on CT images. 
Because the diameter of the aorta was not uniform across different measurement points, two 
measurements were taken 90° apart, and the larger diameter was used in the analysis. The 
diameter of the PA was measured on the line joining the origin of the left PA to the center of the 
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adjacent ascending aorta on the axial section. Enlargement of the PA was defined as PA:A ratio 
>1.13 
 
Statistical analysis 
The statistical analyses were performed with EZR (Saitama Medical Center, Jichi Medical 
University, Saitama, Japan). p-values <0.05 were considered to be significant. Data are presented 
as counts, percentages, or medians with the range or interquartile range. 
Cohen’s κ-coefficient was used to evaluate the intraobserver and interobserver reliability for 
detecting PA:A ratio >1. Spearman’s rank-correlation analysis was used to assess the relationship 
between study outcomes in the subjects and FEV1.0/FVC <70%. Receiver operating characteristic 
(ROC) curves were used to calculate the optimum cutoff values to predict %FEV1.0 <50% as an 
index of severe or very severe airway obstruction,1 %DLCO <75% as an index of pulmonary 
diffusing capacity disorder,3,25 Goddard Score ≥8 as an index of moderate or severe emphysema,31 
and PA:A ratio >1 as an index of PH.13 The optimum cutoff values were defined as the point on 
the ROC curve closest to the upper-left corner of the chart. 
 
Results 
The final analysis included 74 subjects (16 women and 58 men). Table 1 presents the subjects’ 
characteristics. The median age was 73 (range 67–78) years, the median BMI was 22.0 (19.9–
23.8) kg/m2, and the median %FEV1.0 was 63.6% (47.0%–76.1%), with 25 of the subjects having 
FEV1.0/FVC ≥70%. The κ-values for intraobserver and interobserver reliability for detecting PA:A 
ratio >1 were 0.75 (95% confidence interval [CI] 0.57–0.92) and 0.71 (95% CI 0.53–0.90), 
respectively. 
Table 2 presents the results of the linear correlation analysis. DDR-original and DDR-simple 
correlated significantly with %FEV1.0 (r=−0.312, p=0.006 and r=−0.317, p=0.006, 
respectively), %DLCO (r=−0.497, p<0.001 and r=−0.518, p<0.001, respectively), %LAA 
(r=0.381, p=0.001 and r=0.411, p<0.001, respectively), and PA:A ratio (r=0.553, p<0.001 and 
r=0.567, p<0.001, respectively). 6MWD correlated significantly with %DLCO (r=0.360, 
p=0.001) and PA:A ratio (r=−0.340, p=0.003). The lowest level of SpO2 correlated significantly 
with %DLCO (r=0.400, p<0.001), %LAA (r=−0.542, p<0.001), and PA:A ratio (r=−0.562, 
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p<0.001). DDR-original and DDR-simple showed stronger correlations with %FEV1.0 for the 
subjects with FEV1.0/FVC <70% (r=−0.438, p=0.001 and r=−0.455, p=0.001, respectively) than 
for all the subjects. 6MWD and lowest SpO2 both correlated significantly with %FEV1.0 for the 
subjects with FEV1.0/FVC <70% (r=0.313, p=0.043 and r=0.348, p=0.014, respectively). 
Table 3 shows the results of the ROC analysis. DDR-original, DDR-simple, and lowest SpO2 all 
showed high accuracy (area under the ROC curve [AUC] >0.7) for predicting %FEV1.0 
<50%, %DLCO <75%, Goddard Score ≥8, and PA:A ratio >1. The threshold values to 
predict %FEV1.0 <50% were determined for DDR-original (best cutoff point 4.0, AUC 0.73, 95% 
CI 0.62–0.85), DDR-simple (best cutoff point 0.14, AUC 0.74, 95% CI 0.63–0.85), and lowest 
SpO2 (best cutoff point 89, AUC 0.72, 95% CI 0.60–0.84). The threshold values to 
predict %DLCO <75% were determined for DDR-original (best cutoff point 2.7, AUC 0.78, 95% 
CI 0.64–0.91), DDR-simple (best cutoff point 0.09, AUC 0.79, 95% CI 0.66–0.93), and lowest 
SpO2 (best cutoff point 91, AUC 0.75, 95% CI 0.61–0.89). The threshold values to predict 
Goddard Score ≥8 were determined for DDR-original (best cutoff point 4.0, AUC 0.71, 95% CI 
0.59–0.83), DDR-simple (best cutoff point 0.09, AUC 0.73, 95% CI 0.62–0.85), and lowest SpO2 
(best cutoff point 90, AUC 0.79, 95% CI 0.68–0.89). The threshold values to predict PA:A ratio 
>1 were determined for DDR-original (best cutoff point 2.8, AUC 0.82, 95% CI 0.72–0.91), 
DDR-simple (best cutoff point 0.1, AUC 0.83, 95% CI 0.73–0.92), and lowest SpO2 (best cutoff 
point 89, AUC 0.86, 95% CI 0.77–0.95). 
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Discussion 
We investigated the association among DDR, emphysema, and PH in stable COPD patients in 
this study. This study had two main findings. First, DDR showed to be correlated with 
emphysema and PH. Second, DDR-original and DDR-simple showed similar results in all the 
analyses. DDR may become an effective index to assess COPD with a high versatility because it 
can be calculated from the results of 6MWT used worldwide. Therefore, it was worth to find a 
new possibility of DDR in this study. 
DDR was first proposed in 2010 as a new index for the assessment of interstitial lung diseases,19 
with the simple version of DDR proposed in 2014 as an index for the assessment of the exercise 
capacity of COPD patients.20 These previous studies investigated the associations between DDR 
and %FEV1.0 or %DLCO but not associations between DDR and the indexes of emphysema and 
PH.19,20 The present study demonstrated the further usefulness of DDR as an indicator of 
emphysema or PH in COPD patients. Unlike the individual outcomes of the 6MWT (6MWD and 
SpO2), DDR was related significantly with all of the parameters associated with COPD 
(%FEV1.0, %DLCO, %LAA, and PA:A ratio); DDR also demonstrated a strong ability to 
predict %FEV1.0 <50%, %DLCO <75%, Goddard Score ≥8, and PA:A ratio >1. DDR could, 
therefore, become a useful index that reflects the degree of not only airflow obstruction and 
pulmonary diffusing capacity disorder but also emphysema and PH, superior to both 6MWD and 
the lowest SpO2 individually. 
Emphysema is a disorder that involves the destruction of alveoli caused by a decline in alveolar 
surface area and the elasticity of the lung.32,33 The destruction of alveoli progresses before 
symptoms appear or the lung function declines.34 Emphysema affects the patient’s quality of life 
and is associated with exacerbations and deteriorating pulmonary function in subjects without 
airflow obstruction, even when the degree of emphysema is mild.7 It has been reported that PH 
can be caused by the combined results of hypoxia, inflammation, and capillary loss in 
emphysema35 and that there was an association of PH with exercise capacity and mortality in 
COPD patients.36,37 The early diagnosis of emphysema and PH is of great importance for COPD 
patients; however, it is not possible in practice to use CT or RHC for all patients or preliminary 
groups of COPD patients for the diagnosis of emphysema and PH. 6MWD and SpO2 can be 
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measured noninvasively and easily, and it has been reported that 6MWD and EID were each 
related to emphysema and PH.15–18 DDR, an index derived from combining 6MWD and EID, was 
shown in this study to be associated with %LAA and PA:A ratio. Thus, it is suggested that DDR 
could become a useful index that indicates the extent of a patient’s emphysema and PH. 
 Both 6MWD and lowest SpO2, which are widely used as indexes of COPD conditions, showed 
significant correlations with %DLCO, but neither showed a significant correlation with %FEV1.0. 
This contrasted with previous studies, which demonstrated associations between 6MWD or 
lowest SpO2 and %FEV1.0.15,20 It is speculated that these results may have been due to including 
subjects without airflow obstruction in the analysis. As evidence for this, 6MWD and lowest SpO2 
showed significant correlations with %FEV1.0 when only subjects with substantial airflow 
obstruction, indicated by FEV1.0/FVC <70%, were included in the analysis. It has been reported 
that spirometry used to measure %FEV1.0 underdiagnosed mild or early-stage COPD.38 
Conversely, low DLCO was observed in ex-smokers without airflow obstruction, and DLCO has 
been known to be a sensitive index of early-stage COPD.3,39 In the present study, DDR showed 
significant correlations with both %FEV1.0 and %DLCO even when subjects without substantial 
airflow obstruction were included in the analysis. It is therefore suggested that DDR is superior 
to either 6MWD or lowest SpO2 individually in indicating COPD conditions, regardless of the 
degree of airflow obstruction. 
Finally, the results for DDR-original and DDR-simple were similar in all the analyses. This 
suggests that DDR-simple is not inferior to DDR-original in screening COPD conditions. DDR-
original requires a special device to record SpO2 continuously and analyze DA, whereas DDR-
simple can be calculated using a conventional device such as a normal pulse oximeter. This makes 
DDR useful for the assessment of COPD patients in any situation, such as cases receiving medical 
treatment at home or at facilities other than hospitals, without the need for special devices. 
This study had some limitations. First, it was a retrospective study at a single center, and the 
sample size was small. The influence of sex was not examined in this study, even though it has 
been reported that smoking affects women to a greater extent than men. Second, 
echocardiography was not performed for all the subjects, and medical history information 
regarding left ventricular dysfunction was not included in this study even though left ventricular 
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dysfunction causes PA enlargement. These findings should be further inspected by a larger, ideal, 
multicenter, and prospective clinical trial that would take electrocardiography and ventricular 
function into consideration. 
 
Conclusion 
The results of this study suggested that DDR could be a useful index for the assessment of 
COPD patients. The 6MWT is an easy and low-cost method for the assessment of exercise 
capacity in these patients. DDR demonstrated a better ability than the other 6MWT measures to 
predict %FEV1.0 <50%, %DLCO <75%, Goddard Score ≥8, and PA:A ratio >1, so its use could 
help with the early diagnosis of COPD. 
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